Literature DB >> 19540713

Aortobifemoral bypass grafting using expanded polytetrafluoroethylene stretch grafts in patients with occlusive atherosclerotic disease.

Roberto Chiesa1, Enrico Maria Marone, Yamume Tshomba, Davide Logaldo, Renata Castellano, Germano Melissano.   

Abstract

The aim of this retrospective study was to evaluate the performance of bifurcated, longitudinally extensible (stretch), expanded polytetrafluoroethylene (ePTFE) grafts implanted in patients with aortoiliac or aortofemoral occlusive atherosclerotic disease. Between October 1991 and December 2005, 822 consecutive patients (708 men, 114 women; mean age 63.8 years) underwent aortoiliac or aortofemoral reconstruction using a bifurcated ePTFE stretch graft. Preoperatively, all patients had ultrasonographic and arteriographic evaluations and were divided into groups according to the TASC II morphological stratification of iliac lesions. Seventy-seven patients (9.4%) had type B lesions, 314 (38.2%) had type C lesions, and 431 (52.4%) were classified as type D lesions. Endarterectomy of the aorta was required in 172 patients (21%); femoral arteries were endarterectomized in 222 (27%). Femoropopliteal bypass grafting was performed in 18 patients, aortorenal bypass in 12, and mesenteric artery grafting in one. One patient died perioperatively of a myocardial infarction. Perioperative morbidity included cardiac (2.2% of patients), respiratory (0.9%), and gastrointestinal (1.2%) complications, as well as acute renal insufficiency (1.3%). Seven patients had bleeding requiring surgical revision within the first 24hr after surgery. There were four cases (0.5%) of immediate graft thrombosis and five (0.6%) of single-limb graft thrombosis. During a mean follow-up time of 72 months (range 28-170), 58 patients (7.1%) were lost to follow-up and 205 patients (24.9%) died. The primary and secondary graft-patency rates during the observation period were 90.6% and 97.9%, respectively. Twelve late graft occlusions resolved after thrombectomy alone. Eleven cases of single-limb late thrombosis resolved after thrombectomy and profundoplasty. The limb-salvage rate during the observation period in patients who underwent operation for critical limb ischemia was 84.5%. There were nine postoperative graft infections (1.1% infection rate) in the series. Our long-term experience with ePTFE stretch grafts in aortoiliac and aortofemoral reconstruction shows that these prostheses have a high rate of patency and a low rate of graft-related complications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19540713     DOI: 10.1016/j.avsg.2009.01.004

Source DB:  PubMed          Journal:  Ann Vasc Surg        ISSN: 0890-5096            Impact factor:   1.466


  11 in total

1.  Endothelial cell attachment and shear response on biomimetic polymer-coated vascular grafts.

Authors:  Lynn A Dudash; Faina Kligman; Samantha M Sarett; Kandice Kottke-Marchant; Roger E Marchant
Journal:  J Biomed Mater Res A       Date:  2012-05-24       Impact factor: 4.396

Review 2.  Cardiovascular Bio-Engineering: Current State of the Art.

Authors:  Teresa Simon-Yarza; Isabelle Bataille; Didier Letourneur
Journal:  J Cardiovasc Transl Res       Date:  2017-03-06       Impact factor: 4.132

Review 3.  Strategies for managing aortoiliac occlusions: access, treatment and outcomes.

Authors:  Daniel G Clair; Jocelyn M Beach
Journal:  Expert Rev Cardiovasc Ther       Date:  2015-05

4.  Outcomes after redo aortobifemoral bypass for aortoiliac occlusive disease.

Authors:  Salvatore T Scali; Bradley M Schmit; Robert J Feezor; Adam W Beck; Catherine K Chang; Alyson L Waterman; Scott A Berceli; Thomas S Huber
Journal:  J Vasc Surg       Date:  2014-03-21       Impact factor: 4.268

5.  Comparison of Direct and Less Invasive Techniques for the Treatment of Severe Aorto-Iliac Occlusive Disease.

Authors:  Kimberly C Zamor; Andrew W Hoel; Irene B Helenowski; Adam W Beck; Joseph R Schneider; Karen J Ho
Journal:  Ann Vasc Surg       Date:  2017-07-21       Impact factor: 1.466

Review 6.  2016 AHA/ACC Guideline on the Management of Patients With Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.

Authors:  Marie D Gerhard-Herman; Heather L Gornik; Coletta Barrett; Neal R Barshes; Matthew A Corriere; Douglas E Drachman; Lee A Fleisher; Francis Gerry R Fowkes; Naomi M Hamburg; Scott Kinlay; Robert Lookstein; Sanjay Misra; Leila Mureebe; Jeffrey W Olin; Rajan A G Patel; Judith G Regensteiner; Andres Schanzer; Mehdi H Shishehbor; Kerry J Stewart; Diane Treat-Jacobson; M Eileen Walsh
Journal:  Circulation       Date:  2016-11-13       Impact factor: 29.690

7.  In vivo evaluation of biomimetic fluorosurfactant polymer-coated expanded polytetrafluoroethylene vascular grafts in a porcine carotid artery bypass model.

Authors:  Jennifer M Bastijanic; Roger E Marchant; Faina Kligman; Matthew T Allemang; Ryan O Lakin; Daniel Kendrick; Vikram S Kashyap; Kandice Kottke-Marchant
Journal:  J Vasc Surg       Date:  2015-03-28       Impact factor: 4.268

8.  Contemporary outcomes of thoracofemoral bypass.

Authors:  Jeffrey D Crawford; Salvatore T Scali; Kristina A Giles; Martin R Back; Javairiah Fatima; Dean K Arnaoutakis; Scott A Berceli; Gilbert J Upchurch; Thomas S Huber
Journal:  J Vasc Surg       Date:  2018-10-03       Impact factor: 4.268

9.  Advanced age and disease predict lack of symptomatic improvement after endovascular iliac treatment in male veterans.

Authors:  Roland Assi; Kirstyn E Brownson; Michael R Hall; Go Kuwahara; Penny Vasilas; Alan Dardik
Journal:  Yale J Biol Med       Date:  2015-03-04

10.  Endovascular Aneurysm Sealing for Management of Aortic Occlusive Disease.

Authors:  Ahmed Elbasty; Michael Crawford; Darren Morrow
Journal:  EJVES Short Rep       Date:  2017-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.